14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 3rd May 2024 ASND stock ended at $137.20. This is 2.76% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.33% from a day low at $135.16 to a day high of $142.36.
90 days $133.39 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Jul 23, 2020 $142.49 $145.25 $140.42 $140.42 145 017
Jul 22, 2020 $144.15 $146.55 $141.40 $142.54 155 700
Jul 21, 2020 $146.30 $147.50 $143.32 $143.44 237 900
Jul 20, 2020 $143.20 $148.29 $142.46 $145.78 149 300
Jul 17, 2020 $138.20 $143.52 $138.20 $143.52 163 900
Jul 16, 2020 $138.78 $140.85 $137.75 $140.42 133 200
Jul 15, 2020 $139.57 $140.19 $136.72 $139.88 201 400
Jul 14, 2020 $133.61 $138.33 $131.02 $137.84 384 400
Jul 13, 2020 $137.48 $142.46 $134.12 $134.29 184 000
Jul 10, 2020 $141.03 $143.12 $135.51 $136.97 275 100
Jul 09, 2020 $146.88 $147.00 $139.10 $140.00 354 400
Jul 08, 2020 $146.50 $151.69 $143.70 $145.27 1 370 700
Jul 07, 2020 $150.15 $153.24 $147.12 $147.60 243 300
Jul 06, 2020 $152.35 $156.99 $149.54 $151.88 403 600
Jul 02, 2020 $153.51 $154.98 $148.70 $151.00 117 113
Jul 01, 2020 $148.81 $153.10 $147.89 $152.85 156 124
Jun 30, 2020 $145.00 $150.71 $143.01 $147.90 176 792
Jun 29, 2020 $148.93 $148.93 $143.65 $145.21 78 071
Jun 26, 2020 $152.24 $153.70 $147.80 $148.12 186 799
Jun 25, 2020 $151.26 $152.39 $148.59 $151.72 292 794
Jun 24, 2020 $156.07 $158.42 $149.16 $152.75 185 876
Jun 23, 2020 $149.13 $158.93 $148.49 $156.01 403 882
Jun 22, 2020 $146.00 $150.74 $144.58 $149.12 337 725
Jun 19, 2020 $146.38 $147.30 $144.12 $146.07 212 284
Jun 18, 2020 $142.80 $147.63 $141.93 $145.52 151 474
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT